Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen Meeting Abstract
| Authors: | Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; Patel, D.; Lahoud, O.; Shah, G.; Scordo, M.; Chung, D.; Landau, H.; Lesokhin, A.; Korde, N.; Giralt, S.; Usmani, S.; Tan, C. |
| Abstract Title: | Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen |
| Meeting Title: | 19th International Myeloma Society Annual Meeting (IMS) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. |
| Meeting Dates: | 2022 Aug 25-27 |
| Meeting Location: | Los Angeles, CA |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-08-01 |
| Start Page: | S139 |
| End Page: | S140 |
| Language: | English |
| ACCESSION: | WOS:000895909200246 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(22)00520-1 |
| Notes: | Meeting Abstract: P-190 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
